...company's drug vaccine delivery technologies. DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, has completed a Phase I human safety study of the GelVac nasal vaccine delivery system and is actively preparing to initiate clinical trials with influenza (flu) antigen.

Stabilization and delivery of proteins and peptides are critical for the therapeutic applications of these agents that are inherently less stable than small molecule drugs. GelSite...

NOTE: All illustrations and photos have been removed from this article.



More articles from BIOTECH Patent News
BioWarn announces instantaneous detection of avian flu with SmartSense..., July 01, 2006
Leiv Eiriksson Nyskaping obtains United States patent., July 01, 2006
NPS Allelix Corp obtains United States patent., July 01, 2006
Ortho-McNeil obtains United States patent., July 01, 2006
Syngenta obtains United States patent., July 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.